Oncotarget

Corrections:

Correction: Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of epithelial-mesenchymal transition

PDF  |  How to cite

Oncotarget. 2022; 13:118-119. https://doi.org/10.18632/oncotarget.28141

Metrics: PDF 526 views  |   ?  

Xi Wei1,*, Qing Li2,*, Ying Li3,*, Wei Duan2, Chongbiao Huang4, Xiangqian Zheng7, Lei Sun5, Jingtao Luo6, Dong Wang2, Sheng Zhang1, Xiaojie Xin1 and Ming Gao7

1Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
2Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing, China
3The Third Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
4Department of Senior Ward, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
5Department of Biochemistry and Molecular Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
6The Department of Otorhinolaryngology and Maxillofacial Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin Cancer Institute, National Clinical Research Center of Cancer, Tianjin, China
7Department of Thyroid and Cervical Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
*These authors contributed equally to this work

Published: January 13, 2022

Copyright: © 2022 Wei et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: In Figure 4D, the 3rd row, 3rd panel image is an accidental duplicate of the 1st row, 2nd panel image. In addition, the figure legend for 4D has been updated to read, ‘D. A549 cells were indicated by immunofluorescence after APE1 siRNA and inhibitor AT101 treatment. (magnification: 1000×)’. The corrected Figure 4D, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2016; 7:28523–28539. DOI: https://doi.org/10.18632/oncotarget.8660

Figure 4: (D) A549 cells were indicated by immunofluorescence after APE1 siRNA and inhibitor AT101 treatment. (magnification: 1000×).


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 28141